Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Fat tissue produces a variety of secreted proteins (adipocytokines) with important roles in metabolism. We isolated a newly identified adipocytokine, visfatin, that is highly enriched in the visceral fat of both humans and mice and whose expression level in plasma increases during the development of obesity. Visfatin corresponds to a protein identified previously as pre–B cell colony-enhancing factor (PBEF), a 52-kilodalton cytokine expressed in lymphocytes. Visfatin exerted insulin-mimetic effects in cultured cells and lowered plasma glucose levels in mice. Mice heterozygous for a targeted mutation in the visfatin gene had modestly higher levels of plasma glucose relative to wild-type littermates. Surprisingly, visfatin binds to and activates the insulin receptor. Further study of visfatin's physiological role may lead to new insights into glucose homeostasis and/or new therapies for metabolic disorders such as diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Local hypoxia could also play an important role in the attraction and retention of macrophages within the adipose tissue (82) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [82]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Leptin and the regulation of body weight in mammals
Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,237
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,238
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,088
Self-citationMaeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,083
Self-citationFujioka, S., Matsuzawa, Y., Tokunaga, K., & Tarui, S. (1987) · Metabolism · doi:10.1016/0026-0495(87)90063-1 · Cited by 1,207
Self-citationLeptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038
Self-citationCloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1431 · Cited by 1,019
Research works printed but not linked: 1
- B. Samal et al., Mol. Cell. Biol.14, 1431 (1994).
Cited by
Items 801–900 of 1,001
Adipokines in Childhood Obesity
Martos‐Moreno, G. Á., Barrios, V., Chowen, J. A., & Argente, J. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00006-7 · Cited by 37
Quantitative trait loci for individual adipose depot weights in C57BL/6ByJ x 129P3/J F2 mice
Reed, D. R., McDaniel, A. H., Li, X., Tordoff, M. G., & Bachmanov, A. A. (2006) · Mammalian Genome · doi:10.1007/s00335-006-0054-2 · Cited by 30
“Certain genes are expressed in some adipose depots but not in others (Fukuhara et al. 2005; Gesta et al. 2006; Ramis et al. 2002), and these profiles are probably explained in part by the depot-specific functions of adipocytes or other cell types.”
BackgroundOlarescu, N. C., Ueland, T., Lekva, T., Dahl, T. B., Halvorsen, B. L., Aukrust, P., & Bollerslev, J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2417 · Cited by 30
Pharmacological Targeting of Adipocytes/Fat Metabolism for Treatment of Obesity and Diabetes
Pilch, P. F., & Bergenhem, N. C. H. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026104 · Cited by 38
Haider, D. G., Schindler, K., Mittermayer, F., Müller, M., Nowotny, P., Rieger, A., Luger, A., Ludvik, B. H., & Wolzt, M. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100047 · Cited by 32
Sglunda, O., Mann, H. F., Hulejová, H., Kuklová, M., Pecha, O., Pleštilová, L., Filková, M., Pavelká, K., Vencovský, J., & Šenolt, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103495 · Cited by 29
Salemi, Z., rafie, E., Goodarzi, M. T., & Ghaffari, M. A. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.23814 · Cited by 33
Fernández-Ruiz, J. C., Ávila, J. C. G.-D., Martínez‐Fierro, M. L., Veloz, I. G., Cervantes-Villagrana, A. R., Valtierra‐Alvarado, M. A., Serrano, C. J., García-Hernández, M. H., Enciso‐Moreno, J. A., & Castañeda‐Delgado, J. E. (2019) · Journal of Diabetes Research · doi:10.1155/2019/1568457 · Cited by 30
Adiponectin and Leptin Adipocytokines in Metabolic Syndrome: What Is Its Importance?
Albarracin, M. L. G., & Torres, A. Y. F. (2020) · Dubai Diabetes and Endocrinology Journal · doi:10.1159/000510521 · Cited by 40
Mostafa, T. M., El-Gharbawy, N. M., & Werida, R. H. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.05.003 · Cited by 33
Santangelo, C., Varí, R., Scazzocchio, B., Filesi, C., & Masella, R. (2013) · BioFactors · doi:10.1002/biof.1126 · Cited by 31
Malyszko, J., Malyszko, J. S., & Myśliwiec, M. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2008.10.086 · Cited by 29
Astern, J., Collier, A. C., & Kendal‐Wright, C. E. (2012) · Placenta · doi:10.1016/j.placenta.2012.10.008 · Cited by 29
Yu, H., Li, S., Cao, M., Jiang, X., Feng, L., Zhao, J., & Gao, L. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.12 · Cited by 30
Abolfazli, N., Jabali, S., Saber, F. S., Babaloo, Z., & Shirmohammadi, A. (2015) · Journal of Dental Research Dental Clinics Dental Prospects · doi:10.15171/joddd.2015.003 · Cited by 31
Chu, C.-H., Lee, J., Wang, M.-C., Lu, C.-C., Sun, C.-C., Chuang, M.-J., & Lam, H. (2008) · Metabolism · doi:10.1016/j.metabol.2008.05.006 · Cited by 29
“Intravenous injection of recombinant visfatin in mice decreases plasma glucose in a dosedependent fashion [8].”
BackgroundInfluentialTHE CARDIOVASCULAR IMPACT OF VISFATIN - AN INFLAMMATION PREDICTOR BIOMARKER IN METABOLIC SYNDROME
Hognogi, L. D. M., & Vida-Simiti, L. A. (2015) · Medicine and Pharmacy Reports · doi:10.15386/cjmed-591 · Cited by 29
New Insights into Adipokines as Potential Biomarkers for Type-2 Diabetes Mellitus
Catalina, M. O., Redondo, P. C., Granados, M. P., Cantonero, C., Sánchez-Collado, J., Albarrán, L., & López, J. J. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867325666171205162248 · Cited by 32
Can adipokine visfatin be a novel marker of pregnancy‐related disorders in women with obesity?
Wnuk, A., Stangret, A., Wątroba, M., Platek, A. E., Skoda, M., Cendrowski, K., Sawicki, W., & Szukiewicz, D. (2020) · Obesity Reviews · doi:10.1111/obr.13022 · Cited by 35
“Although visfatin was initially reported to bind to an insulin receptor, serious doubts were raised about this thesis, which resulted in the retraction of the article.(18) However, a positive correlation between circulating visfatin levels and IR was reported.”
BackgroundResultInfluentialIncreased expression of inflammatory pathway genes in skeletal muscle during surgery
Witasp, A., Nordfors, L., Schalling, M., Nygren, J., Ljungqvist, O. H., & Thorell, A. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.03.003 · Cited by 30
Lymphscintigraphic evaluation of manual lymphatic drainage for lower extremity lymphedema.
Kafejian-Haddad, A. P., Perez, J., Castiglioni, M. L. V., Miranda, F., & de Figueiredo, L. F. P. (2006) · PubMed · Cited by 29
Endothelial dysfunction in CKD: a new player in town?
Zoccali, C. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm924 · Cited by 29
Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome
Tarkun (2010) · PubMed · doi:10.1684/ecn.2010.0217 · Cited by 28
Maresca, F., Palma, V. D., Bevilacqua, M., Uccello, G., Taglialatela, V., Giaquinto, A., Esposito, G., Trimarco, B., & Cirillo, P. L. (2014) · Angiology · doi:10.1177/0003319713520463 · Cited by 31
Kong, Q., Xia, M., Liang, R., Li, L., Xing Qi, C. U., Sun, Z., & Hu, J. (2014) · Singapore Medical Journal · doi:10.11622/smedj.2014091 · Cited by 28
Association of serum microRNA-21 levels with Visfatin, inflammation, and acute coronary syndromes
Darabi, F., Aghaei, M., Movahedian, A., Elahifar, A., Pourmoghadas, A., & Sarrafzadegan, N. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0913-z · Cited by 29
Abdel-Fadeil, M. R., Allah, E. S. H. A., Iraqy, H. M., Elgamal, D. A., & Abdel‐Ghani, M. A. (2019) · Pathophysiology · doi:10.1016/j.pathophys.2019.02.001 · Cited by 28
Yu, P., Wang, C., Li, W., & Zhang, F. (2019) · Hormone and Metabolic Research · doi:10.1055/a-0867-1333 · Cited by 28
Raigani, S., Carroll, C., Griffith, S., Pendexter, C. A., Rosales, I. A., Deirawan, H., Beydoun, R., Yarmush, M. L., Uygun, K., & Yeh, H. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232886 · Cited by 29
“For example, visfatin was thought to be an insulin-mimetic signaling protein, yet the original manuscript describing its action has been retracted [26].”
BackgroundMelanoma Progression under Obesity: Focus on Adipokines
Olszańska, J., Pietraszek‐Gremplewicz, K., & Nowak, D. (2021) · Cancers · doi:10.3390/cancers13092281 · Cited by 31
“Furthermore, VAT, in contrast to SAT, showed increased expression of fibroblast growth factor 21 and insulin-like growth factor-binding Cancers 2021, 13, 2281. https://doi.org/10.3390/cancers13092281 https://www.mdpi.com/journal/cancers Cancers 2021, 13, 2281 2 of 31 protein (IGFBP)-5 as well as decreased levels of he…”
BackgroundInfluentialThe immune system’s role in PCOS
Shamsi, M., Ghazavi, A., Saeedifar, A. M., Mosayebi, G., Khajehpour, S., & Ganji, A. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-07695-5 · Cited by 45
Adipokines: Deciphering the cardiovascular signature of adipose tissue
Galley, J. C., Singh, S., Awata, W. M. C., Alves, J. V., & Bruder-Nascimento, T. B. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115324 · Cited by 33
Wen, F., Gui, G., Wang, X., Li, Y., Qin, A., Zhou, C., & Zha, X. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117595 · Cited by 28
Derosa, G., Maffioli, P., SALVADEO, S. A. T., Ferrari, I., Gravina, A., Mereu, R., Palumbo, I., Fogari, E., D’Angelo, A., & Cicero, A. F. G. (2010) · Hypertension Research · doi:10.1038/hr.2010.85 · Cited by 30
Han, R., Lan, X., Zhang, L. Z., Ren, G., Jing, Y. J., Li, M. J., Zhang, B.-Q., Zhao, M., Guo, Y., Kang, X. T., et al. (2010) · Journal of Applied Genetics · doi:10.1007/bf03195711 · Cited by 28
Eker, S., Ayaz, L., Tamer, L., & Ulubaş, B. (2009) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365510903484063 · Cited by 29
Chang, L., Yang, R., Wang, M., Liu, J., Wang, Y., Zhang, H., & Li, Y. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31822993ff · Cited by 32
Aoi, W., Naito, Y., & Yoshikawa, T. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2011/676208 · Cited by 30
Kováčiková, M., Vitkova, M., Klimčáková, E., Polak, J., Hejnová, J., Bajzová, M., Kováčová, Z., Viguerie, N., Langin, D., & Štich, V. (2008) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2008.01964.x · Cited by 29
Vu, V. P., Kim, W. I., Fang, X., Liu, Y.-T., Xu, A., & Sweeney, G. (2007) · Endocrinology · doi:10.1210/en.2007-0020 · Cited by 32
Duarte-Pereira, S., Silva, S. S., Azevedo, L., Castro, L., Amorim, A., & Silva, R. M. (2014) · Scientific Reports · doi:10.1038/srep06311 · Cited by 29
Metabolic effects associated with adipose tissue distribution.
Zahorska‐Markiewicz, B. (2006) · PubMed · Cited by 39
Jurdana, M., Petelin, A., Černelič-Bizjak, M., Bizjak, M., Biolo, G., & Pražnikar, Z. J. (2013) · e-SPEN Journal · doi:10.1016/j.clnme.2013.02.001 · Cited by 29
Regulative Effect of Nampt on Tumor Progression and Cell Viability in Human Colorectal Cancer
Lv, X., Zhang, L., Zhu, Y., Said, H. M., Shi, J., & Xu, G. (2015) · Journal of Cancer · doi:10.7150/jca.12341 · Cited by 28
Catabolic effects of gastric bypass in a diet-induced obese rat model
Guijarro, A. I., Kirchner, H., & Meguid, M. M. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000232903.04910.7b · Cited by 30
Bo, S., Ciccone, G., Baldi, I., Gambino, R., Mandrile, C., Durazzo, M., Gentile, L., Cassader, M., Cavallo‐Perin, P., & Pagano, G. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.09.001 · Cited by 29
“Visfatin, also known as pre-B cell colony-enhancing factor, is a novel adipokine secreted by fat tissue and macrophages, and it is involved in the regulation of glucose homeostasis [1,2].”
BackgroundResultInfluentialAdipokines and Their Role in Heart Failure: A Literature Review
Rafaqat, S. (2023) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2023.14111 · Cited by 31
Challenges and opportunities in obesity: the role of adipocytes during tissue fibrosis
Zhang, Q., Lu, C., Lu, F., Liao, Y., Cai, J., & Gao, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1365156 · Cited by 33
“Visfatin is highly enriched in visceral adipose tissue, and its expression level in plasma increases with the development of obesity (35).”
Dahl, T., Ranheim, T., Holm, S., Berge, R., Aukrust, P., & Halvorsen, B. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02515.x · Cited by 27
Romão‐Veiga, M., Weel, I. C., Jaffe, S., Peraçoli, M. T. S., & Witkin, S. S. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-013-3021-7 · Cited by 33
Liu, J., Wang, L., Zhang, A., Di, W., Zhang, X., Wu, L., Yu, J., Zha, J., Lv, S., Cheng, P., et al. (2011) · Endocrine Journal · doi:10.1507/endocrj.k10e-318 · Cited by 26
Proteomics in the characterization of adipose dysfunction in obesity
Brockman, D. A., & Chen, X. (2012) · Adipocyte · doi:10.4161/adip.19129 · Cited by 29
Philp, A. M., Butterworth, S., Davis, E. T., & Jones, S. W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136719 · Cited by 27
Papakonstantinou, Ε., Piperigkou, Z., Karamanos, N. K., & Zolota, V. (2022) · Cancers · doi:10.3390/cancers14174139 · Cited by 33
Obesity: A Doorway to a Molecular Path Leading to Infertility
Ahmad, R., & Haque, M. (2022) · Cureus · doi:10.7759/cureus.30770 · Cited by 37
“Abnormalities in the adipokines may also result in insulin resistance and T2DM [51].”
BackgroundInfluentialVisfatin Mediates SCLC Cells Migration across Brain Endothelial Cells through Upregulation of CCL2
Liu, T., Miao, Z., Jiang, J., Yuan, S., Fang, W., Li, B., & Chen, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160511439 · Cited by 27
Ooi, D. S. Q., Chan, R. M. E., Poh, L. K. S., Loke, K. Y., Heng, C., Chan, Y. H., Gan, S. U., Lee, K., & Lee, Y. S. (2013) · Pediatric Obesity · doi:10.1111/j.2047-6310.2013.00149.x · Cited by 27
Estrogens induce visfatin expression in 3T3-L1 cells
Zhou, J., & Seidel, E. R. (2009) · Peptides · doi:10.1016/j.peptides.2009.12.004 · Cited by 28
Tsouma, I., Kouskouni, E. E., Demeridou, S., Boutsikou, M., Hassiakos, D., Chasiakou, A., Hassiakou, S., & Baka, S. G. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.896896 · Cited by 28
Olszanecka‐Glinianowicz, M., Owczarek, A. J., Bożentowicz‐Wikarek, M., Brzozowska, A., Mossakowska, M., Zdrojewski, T. R., Grodzicki, T. K., Więcek, A., & Chudek, J. T. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.013 · Cited by 27
The comparison of serum vaspin and visfatin concentrations in obese and normal weight women
Saboori, S., Hosseinzadeh‐Attar, M. J., Rad, E. Y., Hosseini, M., Mirzaei, K., & Ahmadivand, Z. (2013) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2013.10.009 · Cited by 27
Göktaş, Z., Owens, S., Boylan, M. L., Syn, D., Shen, C., Reed, D. B., Francisco, S. S., & Wang, S. F. (2013) · Mediators of Inflammation · doi:10.1155/2013/861496 · Cited by 33
Malam, Z., Parodo, J. C., Waheed, F., Szászi, K., Kapùs, A., & Marshall, J. C. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003706 · Cited by 27
Seow, K., Hwang, J., Wang, P.-Y., Ho, L. T., & Juan, C. (2011) · Human Reproduction · doi:10.1093/humrep/der267 · Cited by 32
Plasma visfatin level in women with polycystic ovary syndrome
Dikmen, E., Tarkun, İ., Cantürk, Z., & Çetinarslan, B. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.495796 · Cited by 27
Levels of Adipokines and Some Steroids During the Menstrual Cycle
ŠRÁMKOVÁ, M., Dušková, M., Vítků, J., Včelák, J., Matucha, P., Bradnová, O., Cordeiro, J. D., & Stárka, L. (2015) · Physiological Research · doi:10.33549/physiolres.933116 · Cited by 28
Exercise associated hormonal signals as powerful determinants of an effective fat mass loss
Bajer, B., Vlcek, M., Galusova, A., Imrich, R., & Penesova, A. (2015) · Endocrine Regulations · doi:10.4149/endo_2015_03_151 · Cited by 27
Intensive Glycemic Control Lowers Plasma Visfatin Levels in Patients with Type 2 Diabetes
Zhu, J., Schott, M., Liu, R., Liu, C., Shen, B., Wang, Q., Mao, X., Xu, K., Wu, X., Schinner, S., et al. (2008) · Hormone and Metabolic Research · doi:10.1055/s-0028-1082040 · Cited by 27
Ji, C., Cong, R., Wang, Y., Wang, Y., Zhang, Q., Zhou, X., Xing, Q., & Song, N. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.11.32 · Cited by 29
Serum visfatin and vaspin levels in hepatocellular carcinoma (HCC)
Pazgan−Simon, M., Kukla, M., Zuwała−Jagiełło, J., Derra, A., Bator, M., Menżyk, T., Lekstan, A., Grzebyk, E., & Simon, K. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0227459 · Cited by 27
“Study performed by Fukuhara, et al indicated that visfatin lowers glucose serum levels and decreases IR [30].”
MethodIbáñez, L., López‐Bermejo, A., Díaz, M., Enríquez, G., Valls, C., & De Zegher, F. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03137.x · Cited by 28
Role of visfatin, insulin-like growth factor-I and insulin in fetal growth
Briana, D. D., Boutsikou, M., Gourgiotis, D., Kontara, L., Baka, S. G., Iacovidou, N. M., Hassiakos, D., & Malamitsi‐Puchner, A. (2007) · Journal of Perinatal Medicine · doi:10.1515/jpm.2007.071 · Cited by 27
Adiponectin and visfatin concentrations in children treated with valproic acid
Rauchenzauner, M., Haberlandt, E., Scholl‐Bürgi, S., Ernst, B., Hoppichler, F., Karall, D., Ebenbichler, C. F., Rostasy, K. M., & Luef, G. J. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01460.x · Cited by 27
“In contrast, the novel adipocytokine visfatin was described as a protein, able to mimic insulin functions and to activate the intracellular signalling cascade for insulin (Fukuhara et al., 2005).”
BackgroundReview article: The role of adipose tissue in uraemia‐related insulin resistance
Manolescu, B. N., Stoian, I. A.-M., Atanasiu, V., Buşu, C., & Lupescu, O. (2008) · Nephrology · doi:10.1111/j.1440-1797.2008.01022.x · Cited by 26
Senescence suppressors: their practical importance in replicative lifespan extension in stem cells
Hwang, E. S. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1685-1 · Cited by 32
Serum adipokine concentrations in dogs with diabetes mellitus: a pilot study
Kim, A. Y., Kim, H., Kang, J., & Yang, M. (2015) · Journal of Veterinary Science · doi:10.4142/jvs.2015.16.3.333 · Cited by 27
Wang, G., Tian, W., Liu, Y., Ju, Y., Shen, Y., Zhao, S., Zhang, B., & Li, Y. (2016) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12623 · Cited by 26
Sawicka, K., Michalska-Jakubus, M. M., Potembska, E., Kowal, M., Pietrzak, A., & Krasowska, D. (2019) · Advances in Dermatology and Allergology · doi:10.5114/ada.2018.79104 · Cited by 26
Zheng, M., Lü, N., Ren, M., & Chen, H. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01549-3 · Cited by 27
Biomarkers of cardiometabolic complications in survivors of childhood acute lymphoblastic leukemia
Morel, S., Léveillé, P., Samoilenko, M., Franco, A., England, J., Malaquin, N., Tu, V., Cardin, G. B., Drouin, S., Rodier, F., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-78493-x · Cited by 31
Adipokines as Immune Cell Modulators in Multiple Sclerosis
Rijnsburger, M., Djuric, N., Mulder, I. A., & de Vries, H. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910845 · Cited by 29
Female obesity: Association with endocrine disruption and reproductive dysfunction
Baraskar, K., Thakur, P., Shrivastava, R., & Shrivastava, V. K. (2021) · Obesity Medicine · doi:10.1016/j.obmed.2021.100375 · Cited by 28
Straburzyńska‐Lupa, A., Nowak, A., Pilaczyńska-Szczȩśniak, Ł., Straburzyńska‐Migaj, E., Romanowski, W., Karolkiewicz, J., & Śliwicka, E. (2010) · PubMed · Cited by 26
Schulz, C., Paulus, K., & Lehnert, H. (2010) · Results and problems in cell differentiation · doi:10.1007/978-3-642-14426-4_16 · Cited by 27
Lemor, A., Mielenz, M., Altmann, M., Von Borell, E., & Sauerwein, H. (2010) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2010.00987.x · Cited by 26
Serum visfatin in Asian women with polycystic ovary syndrome
Jongwutiwes, T., Lertvikool, S., Leelaphiwat, S., Rattanasiri, S., Jultanmas, R., & Weerakiet, S. (2009) · Gynecological Endocrinology · doi:10.1080/09513590903015478 · Cited by 27
Serum Adipokine Concentrations in Dogs with Acute Pancreatitis
Paek, J., Kang, J., Kim, H. ‐., Lee, I., Seo, K., & Yang, M. (2014) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.12437 · Cited by 26
Lack of direct insulin-like action of visfatin/Nampt/PBEF1 in human adipocytes
Wanecq, E., Prévot, D., & Carpéné, C. (2009) · Journal of Physiology and Biochemistry · doi:10.1007/bf03185930 · Cited by 26
In utero undernutrition reduces diabetes incidence in non-obese diabetic mice
Oge, A., ISGANAITIS, E. M., Jimenez-Chillaron, J., Reamer, C., Faucette, R., Barry, K., Przybyla, R., & Patti, M. (2007) · Diabetologia · doi:10.1007/s00125-007-0617-0 · Cited by 27
Lee, I. S., Shin, G., & Choue, R. (2009) · Inflammation Research · doi:10.1007/s00011-009-0113-8 · Cited by 30
Huang, Q., Dai, W.-M., Jie, Y., Yu, G., Fan, X., & Wu, A. (2012) · Peptides · doi:10.1016/j.peptides.2012.11.006 · Cited by 26
Bokarewa, M. I., Erlandsson, M. C., Bjersing, J. L., Dehlin, M., & Mannerkorpi, K. (2014) · Mediators of Inflammation · doi:10.1155/2014/627041 · Cited by 29
Johansson, L. M., Johansson, L. E., & Ridderstråle, M. (2008) · Metabolism · doi:10.1016/j.metabol.2008.06.011 · Cited by 29
“011 levels in visceral and subcutaneous adipose tissue (VAT and SAT) and the relation to visfatin plasma levels, obesity, and type 2 diabetes mellitus have been inconsistent [1,4-8].”
BackgroundInfluentialNampt/PBEF/Visfatin: A New Player in β Cell Physiology and in Metabolic Diseases?
Tanaka, T., & Nabeshima, Y. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.004 · Cited by 26
Hung, W., Yu, T., Hsu, C., Lu, L.-F., Chung, F., Tsai, I., Lu, Y., Houng, J., Lee, Y., & Wang, C.-P. (2015) · Clinical and investigative medicine · doi:10.25011/cim.v38i3.22705 · Cited by 25
Robust signaling networks of the adipose secretome
Breitling, R. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.08.006 · Cited by 26
Dessì, A., Pravettoni, C., Marincola, F. C., Schirru, A., & Fanos, V. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1034694 · Cited by 32
Xiao, J., Sun, B., Li, M., Wu, Y., & Sun, X. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24257 · Cited by 25
“Visfatin, a newly discovered adipocytokine, has been shown to possess anti-diabetic (Fukuhara et al., 2005), anti-tumor (Khan et al., 2006), and pro-inflammatory properties (Moschen et al., 2007).”
BackgroundHosseinzadeh‐Attar, M. J., Golpaie, A., Foroughi, M., Hosseinpanah, F., Zahediasl, S., & Azizi, F. (2016) · Journal of Endocrinological Investigation · doi:10.1007/s40618-016-0457-1 · Cited by 25
Thakre, A., Gupta, M. K., Magar, S. P., Bahiram, K. B., Sardar, V. M., Korde, J. P., Bonde, S. W., & Hyder, I. (2020) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2020.106583 · Cited by 28
Metadata
- Authors
- Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., Watanabe, E., Takagi, T., Akiyoshi, M., Ohtsubo, T., Kihara, S., Yamashita, S., Makishima, M., Funahashi, T., Yamanaka, S., Hiramatsu, R., Matsuzawa, Y., & Shimomura, I.
- Affiliations
- Japan Society for the Promotion of Science (JP)
- Department of Medicine and Pathophysiology, Graduate School of Medicine, and Department of Organismal Biosystems, Graduate School of Frontier Biosciences, Osaka University, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan.
- Corresponding author
- Fukuhara, Atsunori
- Matsuda, Morihiro
- Nishizawa, Masako
- Shimomura, Iichiro
- ORCID
- Venue
- Science
- Published
- 2005-01-21
- Volume
- 307
- Issue
- 5708
- Pages
- 426-430
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2135110328
- Cited by
- 1,906
- References
- 17
- Citations by year
- 2026: 10 · 2025: 24 · 2024: 45 · 2023: 55 · 2022: 62 · 2021: 53 · 2020: 52 · 2019: 76 · 2018: 93 · 2017: 71 · 2016: 82 · 2015: 122 · 2014: 117 · 2013: 128 · 2012: 107
- FWCI
- 74.12
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2007-10-26)
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- visfatin, PBEF, visceral fat, adipokines, insulin-like activity, insulin receptor, glucose homeostasis, obesity, diabetes mellitus, plasma glucose, knockout mice
- MeSH terms
- Adipose Tissue, Animals, Binding Sites, Blood Glucose, Cell Line, Cells, Cultured, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Female, Gene Expression Regulation, Humans, Insulin, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Obese, Phosphorylation, Receptor, Insulin, Recombinant Proteins, Viscera, Signal Transduction, Cytokines, Adipocytes, Gene Targeting, Molecular Mimicry, Gene Expression Profiling, Muscle Cells, Subcutaneous Tissue, Mice, Nicotinamide Phosphoribosyltransferase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.